Nor sold. Pacton pulled out of another deal, they've been busy. That being the case potential buyers may want to see this rubber stamped first.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025